Processa CEO presents at MedInvest conference; no specific material data in filing

Processa Pharmaceuticals, Inc.

CEO George Ng presented at MedInvest Biotech + Pharma Investor Conference on April 3, 2024 in NYC.
Presentation titled 'Next Generation Chemotherapy: Improved Treatment for More Patients' was at 10:55 AM ET.
President R&D David Young attended the meeting virtually.
Presentation furnished as Exhibit 99.1 but not included in this filing; no numbers or clinical data disclosed.
Company directs investors to website for presentation and routine disclosure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.